Record Information |
---|
Version | 2.0 |
---|
Created at | 2005-11-16 15:48:42 UTC |
---|
Updated at | 2022-02-17 17:51:10 UTC |
---|
NP-MRD ID | NP0000124 |
---|
Secondary Accession Numbers | None |
---|
Natural Product Identification |
---|
Common Name | Citrulline |
---|
Description | Citrulline, also known as Cit or δ-ureidonorvaline, belongs to the class of organic compounds known as l-alpha-amino acids. These are alpha amino acids which have the L-configuration of the alpha-carbon atom. Citrulline has the formula H2NC(O)NH(CH2)3CH(NH2)CO2H. Citrulline exists in all living species, ranging from bacteria to humans. Within humans, citrulline participates in a number of enzymatic reactions. In particular, citrulline can be biosynthesized from carbamoyl phosphate and ornithine which is catalyzed by the enzyme ornithine carbamoyltransferase. In addition, citrulline and L-aspartic acid can be converted into argininosuccinic acid through the action of the enzyme argininosuccinate synthase. In humans, citrulline is involved in the metabolic disorder called argininemia. Citrulline has also been found to be associated with several diseases such as ulcerative colitis, rheumatoid arthritis, and citrullinemia type II. Citrulline has also been linked to several inborn metabolic disorders including argininosuccinic aciduria and fumarase deficiency. Outside of the human body, citrulline is found, on average, in the highest concentration in a few different foods such as wheats, oats, and cucumbers and in a lower concentration in swiss chards, yellow wax beans, and potato. Citrulline has also been detected, but not quantified in several different foods, such as epazotes, lotus, common buckwheats, strawberry guava, and italian sweet red peppers. Citrulline is a potentially toxic compound. Proteins that normally contain citrulline residues include myelin basic protein (MBP), filaggrin, and several histone proteins, whereas other proteins, such as fibrin and vimentin are susceptible to citrullination during cell death and tissue inflammation. Citrulline is also produced as a byproduct of the enzymatic production of nitric oxide from the amino acid arginine, catalyzed by nitric oxide synthase. It is also produced from arginine as a byproduct of the reaction catalyzed by NOS family (NOS; EC1.14.13.39). |
---|
Structure | N[C@@H](CCCNC(N)=O)C(O)=O InChI=1S/C6H13N3O3/c7-4(5(10)11)2-1-3-9-6(8)12/h4H,1-3,7H2,(H,10,11)(H3,8,9,12)/t4-/m0/s1 |
---|
Synonyms | Value | Source |
---|
(S)-2-Amino-5-ureidopentanoic acid | ChEBI | 2-Amino-5-ureidovaleric acid | ChEBI | alpha-Amino-delta-ureidovaleric acid | ChEBI | Cit | ChEBI | delta-Ureidonorvaline | ChEBI | L-2-Amino-5-ureidovaleric acid | ChEBI | N(5)-(Aminocarbonyl)-L-ornithine | ChEBI | N5-(Aminocarbonyl)ornithine | ChEBI | N5-Carbamoylornithine | ChEBI | N(delta)-Carbamylornithine | ChEBI | (S)-2-Amino-5-ureidopentanoate | Generator | 2-Amino-5-ureidovalerate | Generator | a-Amino-delta-ureidovalerate | Generator | a-Amino-delta-ureidovaleric acid | Generator | alpha-Amino-delta-ureidovalerate | Generator | Α-amino-δ-ureidovalerate | Generator | Α-amino-δ-ureidovaleric acid | Generator | Δ-ureidonorvaline | Generator | L-2-Amino-5-ureidovalerate | Generator | N(Δ)-carbamylornithine | Generator | a-Amino-δ-ureidovalerate | HMDB | a-Amino-δ-ureidovaleric acid | HMDB | (2S)-2-Amino-5-(carbamoylamino)pentanoate | HMDB | (2S)-2-Amino-5-(carbamoylamino)pentanoic acid | HMDB | (S)-2-Amino-5-(aminocarbonyl)aminopentanoate | HMDB | (S)-2-Amino-5-(aminocarbonyl)aminopentanoic acid | HMDB | 2-Amino-5-uredovalerate | HMDB | 2-Amino-5-uredovaleric acid | HMDB | a-Amino-D-ureidovalerate | HMDB | a-Amino-D-ureidovaleric acid | HMDB | alpha-Amino-gamma-ureidovalerate | HMDB | alpha-Amino-gamma-ureidovaleric acid | HMDB | Amino-ureidovalerate | HMDB | Amino-ureidovaleric acid | HMDB | CIR | HMDB | Cytrulline | HMDB | D-Ureidonorvaline | HMDB | DL-Citrulline | HMDB | Gammaureidonorvaline | HMDB | H-Cit-OH | HMDB | L(+)-2-Amino-5-ureidovalerate | HMDB | L(+)-2-Amino-5-ureidovaleric acid | HMDB | L(+)-Citrulline | HMDB | L-2-Amino-5-ureido-valerate | HMDB | L-2-Amino-5-ureido-valeric acid | HMDB | L-Citrulline | HMDB | L-Cytrulline | HMDB | L-N5-Carbamoyl-ornithine | HMDB | N()-Carbamylornithine | HMDB | N(5)-(Aminocarbonyl)-DL-ornithine | HMDB | N-Carbamylornithine | HMDB | N5-(Aminocarbonyl)-L-ornithine | HMDB | N5-(Aminocarbonyl)-ornithine | HMDB | N5-Carbamoyl-L-ornithine | HMDB | N5-Carbamylornithine | HMDB | ND-Carbamylornithine | HMDB | Ndelta-carbamy-ornithine | HMDB | Ndelta-carbamylornithine | HMDB | Ngamma-carbamylornithine | HMDB | Sitrulline | HMDB | Ureidonorvaline | HMDB | Ureidovalerate | HMDB | Ureidovaleric acid | HMDB |
|
---|
Chemical Formula | C6H13N3O3 |
---|
Average Mass | 175.1857 Da |
---|
Monoisotopic Mass | 175.09569 Da |
---|
IUPAC Name | (2S)-2-amino-5-(carbamoylamino)pentanoic acid |
---|
Traditional Name | L-citrulline |
---|
CAS Registry Number | 372-75-8 |
---|
SMILES | N[C@@H](CCCNC(N)=O)C(O)=O |
---|
InChI Identifier | InChI=1S/C6H13N3O3/c7-4(5(10)11)2-1-3-9-6(8)12/h4H,1-3,7H2,(H,10,11)(H3,8,9,12)/t4-/m0/s1 |
---|
InChI Key | RHGKLRLOHDJJDR-BYPYZUCNSA-N |
---|
Experimental Spectra |
---|
|
| Spectrum Type | Description | Depositor Email | Depositor Organization | Depositor | Deposition Date | View |
---|
1D NMR | 1H NMR Spectrum (1D, 700 MHz, H2O, simulated) | Ahselim | | | 2022-02-17 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 500 MHz, H2O, experimental) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 2D NMR | [1H, 13C]-HSQC NMR Spectrum (2D, 600 MHz, H2O, experimental) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum |
| Predicted Spectra |
---|
|
| Not Available | Chemical Shift Submissions |
---|
|
| Spectrum Type | Description | Depositor Email | Depositor Organization | Depositor | Deposition Date | View |
---|
1D NMR | 13C NMR Spectrum (1D, 400 MHz, H2O, simulated) | varshavi.d26@gmail.com | Not Available | Not Available | 2021-07-21 | View Spectrum |
| Species |
---|
Species of Origin | |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as l-alpha-amino acids. These are alpha amino acids which have the L-configuration of the alpha-carbon atom. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organic acids and derivatives |
---|
Class | Carboxylic acids and derivatives |
---|
Sub Class | Amino acids, peptides, and analogues |
---|
Direct Parent | L-alpha-amino acids |
---|
Alternative Parents | |
---|
Substituents | - L-alpha-amino acid
- Fatty acid
- Isourea
- Amino acid
- Carboximidic acid derivative
- Carboxylic acid
- Monocarboxylic acid or derivatives
- Carboximidamide
- Amine
- Hydrocarbon derivative
- Primary amine
- Organooxygen compound
- Organonitrogen compound
- Organic oxide
- Primary aliphatic amine
- Organopnictogen compound
- Imine
- Organic oxygen compound
- Organic nitrogen compound
- Carbonyl group
- Aliphatic acyclic compound
|
---|
Molecular Framework | Aliphatic acyclic compounds |
---|
External Descriptors | |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Properties | Property | Value | Reference |
---|
Melting Point | 235.5 °C | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | 212 mg/mL | Not Available | LogP | -3.19 | Sangster, J. (1993). LOGKOW- a Databank of Evaluated Octanol-Water Partition Coefficients. Sangster Research Laboratories, Montreal. |
|
---|
Predicted Properties | |
---|
General References | - Cynober LA: Plasma amino acid levels with a note on membrane transport: characteristics, regulation, and metabolic significance. Nutrition. 2002 Sep;18(9):761-6. [PubMed:12297216 ]
- Rainesalo S, Keranen T, Palmio J, Peltola J, Oja SS, Saransaari P: Plasma and cerebrospinal fluid amino acids in epileptic patients. Neurochem Res. 2004 Jan;29(1):319-24. [PubMed:14992292 ]
- Le Boucher J, Charret C, Coudray-Lucas C, Giboudeau J, Cynober L: Amino acid determination in biological fluids by automated ion-exchange chromatography: performance of Hitachi L-8500A. Clin Chem. 1997 Aug;43(8 Pt 1):1421-8. [PubMed:9267323 ]
- Crenn P, Coudray-Lucas C, Thuillier F, Cynober L, Messing B: Postabsorptive plasma citrulline concentration is a marker of absorptive enterocyte mass and intestinal failure in humans. Gastroenterology. 2000 Dec;119(6):1496-505. [PubMed:11113071 ]
- Melis GC, Boelens PG, van der Sijp JR, Popovici T, De Bandt JP, Cynober L, van Leeuwen PA: The feeding route (enteral or parenteral) affects the plasma response of the dipetide Ala-Gln and the amino acids glutamine, citrulline and arginine, with the administration of Ala-Gln in preoperative patients. Br J Nutr. 2005 Jul;94(1):19-26. [PubMed:16115328 ]
- DeLong GR, Glick TH: Ammonia metabolism in Reye syndrome and the effect of citrulline. Ann Neurol. 1982 Jan;11(1):53-8. [PubMed:7059128 ]
- Jianfeng G, Weiming Z, Ning L, Fangnan L, Li T, Nan L, Jieshou L: Serum citrulline is a simple quantitative marker for small intestinal enterocytes mass and absorption function in short bowel patients. J Surg Res. 2005 Aug;127(2):177-82. [PubMed:15921697 ]
- Liappis N, Pohl B, Weber HP, el-Karkani H: [Free amino acids in the saliva of children with phenylketonuria]. Klin Padiatr. 1986 Jan-Feb;198(1):25-8. [PubMed:3959486 ]
- Fleisher LD, Harris CJ, Mitchell DA, Nadler HL: Citrullinemia: prenatal diagnosis of an affected fetus. Am J Hum Genet. 1983 Jan;35(1):85-90. [PubMed:6823975 ]
- Potter MA, Zeesman S, Brennan B, Kobayashi K, Gao HZ, Tabata A, Saheki T, Whelan DT: Pregnancy in a healthy woman with untreated citrullinemia. Am J Med Genet A. 2004 Aug 15;129A(1):77-82. [PubMed:15266621 ]
- Wheatley DN, Kilfeather R, Stitt A, Campbell E: Integrity and stability of the citrulline-arginine pathway in normal and tumour cell lines. Cancer Lett. 2005 Sep 28;227(2):141-52. [PubMed:16112417 ]
- Reparon-Schuijt CC, van Esch WJ, van Kooten C, Schellekens GA, de Jong BA, van Venrooij WJ, Breedveld FC, Verweij CL: Secretion of anti-citrulline-containing peptide antibody by B lymphocytes in rheumatoid arthritis. Arthritis Rheum. 2001 Jan;44(1):41-7. [PubMed:11212174 ]
- Maruyama H, Ogawa M, Nishio T, Kobayashi K, Saheki T, Sunohara N: Citrullinemia type II in a 64-year-old man with fluctuating serum citrulline levels. J Neurol Sci. 2001 Jan 1;182(2):167-70. [PubMed:11137523 ]
- McLaurin J, Moscarello MA: The preparation of antibodies reactive against citrulline-containing charge isomers of myelin basic protein but not against the arginine-containing charge isomers. Anal Biochem. 1990 Dec;191(2):272-7. [PubMed:1707596 ]
- Facchinetti F, Longo M, Piccinini F, Neri I, Volpe A: L-arginine infusion reduces blood pressure in preeclamptic women through nitric oxide release. J Soc Gynecol Investig. 1999 Jul-Aug;6(4):202-7. [PubMed:10486782 ]
- Origuchi Y, Ushijima T, Sakaguchi M, Akaboshi I, Matsuda I: Citrullinemia presenting as uncontrollable epilepsy. Brain Dev. 1984;6(3):328-31. [PubMed:6486381 ]
- Booth FA, Haworth JC, Dilling LA, Perry TL, Greenberg CR, Seargeant LE, Penn AM, Rhead WJ: Mitochondrial encephalomyopathy with associated aminoacidopathy in a male sibship. J Pediatr. 1989 Jul;115(1):81-8. [PubMed:2738799 ]
- Ciesielski O, Biesiekierska M, Panthu B, Soszynski M, Pirola L, Balcerczyk A: Citrullination in the pathology of inflammatory and autoimmune disorders: recent advances and future perspectives. Cell Mol Life Sci. 2022 Jan 25;79(2):94. doi: 10.1007/s00018-022-04126-3. [PubMed:35079870 ]
|
---|